Home › Acute Lymphoblastic Leukemia › Virginia
Acute Lymphoblastic Leukemia clinical trials in Virginia
9 studies for Acute Lymphoblastic Leukemia are looking for participants at sites in Virginia.
Cities in Virginia
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Chesapeake Regional Medical Center, Chesapeake
- Augusta Health Center for Cancer and Blood Disorders, Fishersville
- Bon Secours Memorial Regional Medical Center, Mechanicsville
- and 7 more
RecruitingObservational studyHealthy volunteers welcome
Ages 40 to 75 · All sexes · Updated Oct 2, 2026 · NCT05334069A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- Sarah Cannon, Virginia Oncology Associates, Norfolk
RecruitingPhase 2
6 Months · All sexes · Updated Sep 28, 2026 · NCT06514794The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- University of Virginia Cancer Center, Charlottesville
- Inova Fairfax Hospital, Falls Church
- Children's Hospital of The King's Daughters, Norfolk
- and 2 more
RecruitingPhase 1/2
Up to age 22 · All sexes · Updated Aug 25, 2026 · NCT04726241A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- University of Virginia, Charlottesville
- Virginia Commonwealth University, Richmond
RecruitingObservational study
All ages · All sexes · Updated Jul 6, 2026 · NCT01351545TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia II
- Children's Hospital of The King's Daughters, Norfolk
RecruitingPhase 1/2
Up to age 1 · All sexes · Updated Jun 3, 2026 · NCT05848687Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- Virginia Commonwealth University/Massey Cancer Center, Richmond
RecruitingObservational study
All ages · All sexes · Updated May 18, 2026 · NCT01790152A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- University of Virginia, Charlottesville
- Virginia Cancer Specialists, Fairfax
- Virginia Oncology Associates, Norfolk
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Mar 24, 2026 · NCT04988555A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
- University of Virginia, Charlottesville
RecruitingPhase 2
Ages 18 to 66 · All sexes · Updated Mar 17, 2026 · NCT06859424Bright Ideas - CIN Feasibility Study
- Inova Children's Hospital, Falls Church
Recruiting
Ages 4 to 18 · All sexes · Updated Jan 31, 2025 · NCT04929899From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.